BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15797521)

  • 21. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
    Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
    J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of an on-target sample preparation system for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in conjunction with normal-flow peptide high-performance liquid chromatography for peptide mass fingerprint analyses.
    McComb ME; Perlman DH; Huang H; Costello CE
    Rapid Commun Mass Spectrom; 2007; 21(1):44-58. PubMed ID: 17133622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
    Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
    Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry.
    Umar A; Dalebout JC; Timmermans AM; Foekens JA; Luider TM
    Proteomics; 2005 Jul; 5(10):2680-8. PubMed ID: 15892168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma.
    Ho DW; Yang ZF; Wong BY; Kwong DL; Sham JS; Wei WI; Yuen AP
    Cancer; 2006 Jul; 107(1):99-107. PubMed ID: 16708360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative proteomic analyses of the yeast Saccharomyces cerevisiae KNU5377 strain against menadione-induced oxidative stress.
    Kim I; Yun H; Jin I
    J Microbiol Biotechnol; 2007 Feb; 17(2):207-17. PubMed ID: 18051751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
    Moshkovskii SA; Serebryakova MV; Kuteykin-Teplyakov KB; Tikhonova OV; Goufman EI; Zgoda VG; Taranets IN; Makarov OV; Archakov AI
    Proteomics; 2005 Sep; 5(14):3790-7. PubMed ID: 16121334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
    Liu DH; Zhang LM; Feng WY
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
    Diamandis EP
    Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
    Meilhac O; Delbosc S; Michel JB
    Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
    Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer.
    Roesch-Ely M; Nees M; Karsai S; Ruess A; Bogumil R; Warnken U; Schnölzer M; Dietz A; Plinkert PK; Hofele C; Bosch FX
    Oncogene; 2007 Jan; 26(1):54-64. PubMed ID: 16819514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
    Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
    Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.